Terms: = Leukemia AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
11 results:
1. Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis.
Wolach O; Frisch A; Shargian L; Yeshurun M; Apel A; Vainstein V; Moshe Y; Shimony S; Amit O; Bar-On Y; Ofran Y; Raanani P; Nachmias B; Ram R
Ann Hematol; 2022 Aug; 101(8):1719-1726. PubMed ID: 35732976
[TBL] [Abstract] [Full Text] [Related]
2. [Prognostic factors of autologous hematopoietic stem cell transplantation in intermediate-risk acute myeloid leukemia patients with minimal residual disease negativity].
Lian JY; Ye PP; Cao JJ; Chen D; Wang TT; Si T; Yuan JJ; Lu Y
Zhonghua Nei Ke Za Zhi; 2022 Jun; 61(6):673-677. PubMed ID: 35673748
[TBL] [Abstract] [Full Text] [Related]
3. Sedation Practices for Lumbar Punctures in Patients With Acute Lymphoblastic leukemia: A Multicenter Retrospective Study Using Pediatric Health Information Systems.
Wright ML; O'Brien SH; Schloss B; Stanek JR; Reed S
J Pediatr Hematol Oncol; 2022 Oct; 44(7):e982-e987. PubMed ID: 35293881
[TBL] [Abstract] [Full Text] [Related]
4. MLL1 is required for maintenance of intestinal stem cells.
Goveas N; Waskow C; Arndt K; Heuberger J; Zhang Q; Alexopoulou D; Dahl A; Birchmeier W; Anastassiadis K; Stewart AF; Kranz A
PLoS Genet; 2021 Dec; 17(12):e1009250. PubMed ID: 34860830
[TBL] [Abstract] [Full Text] [Related]
5. Forkhead‑box A1 regulates tumor cell growth and predicts prognosis in colorectal cancer.
Park YL; Kim SH; Park SY; Jung MW; Ha SY; Choi JH; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
Int J Oncol; 2019 Jun; 54(6):2169-2178. PubMed ID: 31081047
[TBL] [Abstract] [Full Text] [Related]
6. PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D.
Toska E; Osmanbeyoglu HU; Castel P; Chan C; Hendrickson RC; Elkabets M; Dickler MN; Scaltriti M; Leslie CS; Armstrong SA; Baselga J
Science; 2017 Mar; 355(6331):1324-1330. PubMed ID: 28336670
[TBL] [Abstract] [Full Text] [Related]
7. Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study.
Savlı H; Galimberti S; Sünnetçi D; Canesastraro M; Palumbo G; Nagy B; Di Raimondo F; Petrini M
Turk J Haematol; 2015 Sep; 32(3):206-12. PubMed ID: 25913414
[TBL] [Abstract] [Full Text] [Related]
8. Establishment of active chromatin structure at enhancer elements by mixed-lineage leukemia 1 to initiate estrogen-dependent gene expression.
Jeong KW; Andreu-Vieyra C; You JS; Jones PA; Stallcup MR
Nucleic Acids Res; 2014 Feb; 42(4):2245-56. PubMed ID: 24288367
[TBL] [Abstract] [Full Text] [Related]
9. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.
Magnani L; Ballantyne EB; Zhang X; Lupien M
PLoS Genet; 2011 Nov; 7(11):e1002368. PubMed ID: 22125492
[TBL] [Abstract] [Full Text] [Related]
10. Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype.
Neben K; Schnittger S; Brors B; Tews B; Kokocinski F; Haferlach T; Müller J; Hahn M; Hiddemann W; Eils R; Lichter P; Schoch C
Oncogene; 2005 Feb; 24(9):1580-8. PubMed ID: 15674343
[TBL] [Abstract] [Full Text] [Related]
11. Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots.
Bowen DT; Padua RA; Burnett AK; deCastro CM; Kaufman RE
Leukemia; 1993 Nov; 7(11):1883-5. PubMed ID: 7694008
[TBL] [Abstract] [Full Text] [Related]
